Fundraising Fox
Moleculeralabs
Founded 2011 · 14 employees on LinkedIn · 2 known investors
Find your way into Moleculeralabs
Sign up to see every warm intro you have to Moleculeralabs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Moleculeralabs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.
Investors · 2
Related companies · 1
Companies working in the same space as Moleculeralabs.
Frequently asked questions
- What does Moleculeralabs do?
- Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.
- Who are Moleculeralabs's investors?
- Moleculeralabs's investors include Plains Ventures, Prolog Ventures.